PTPN14 phosphatase and YAP promote TGFβ signalling in rheumatoid synoviocytes.

Annals of the Rheumatic Diseases
Angel BottiniNunzio Bottini

Abstract

We aimed to understand the role of the tyrosine phosphatase PTPN14-which in cancer cells modulates the Hippo pathway by retaining YAP in the cytosol-in fibroblast-like synoviocytes (FLS) from patients with rheumatoid arthritis (RA). Gene/protein expression levels were measured by quantitative PCR and/or Western blotting. Gene knockdown in RA FLS was achieved using antisense oligonucleotides. The interaction between PTPN14 and YAP was assessed by immunoprecipitation. The cellular localisation of YAP and SMAD3 was examined via immunofluorescence. SMAD reporter studies were carried out in HEK293T cells. The RA FLS/cartilage coimplantation and passive K/BxN models were used to examine the role of YAP in arthritis. RA FLS displayed overexpression of PTPN14 when compared with FLS from patients with osteoarthritis (OA). PTPN14 knockdown in RA FLS impaired TGFβ-dependent expression of MMP13 and potentiation of TNF signalling. In RA FLS, PTPN14 formed a complex with YAP. Expression of PTPN14 or nuclear YAP-but not of a non-YAP-interacting PTPN14 mutant-enhanced SMAD reporter activity. YAP promoted TGFβ-dependent SMAD3 nuclear localisation in RA FLS. Differences in epigenetic marks within Hippo pathway genes, including YAP, were found be...Continue Reading

References

Feb 24, 2004·Molecular Pharmacology·Stacey DaCosta ByfieldAnita B Roberts
May 25, 2004·Science·Zhenghe WangVictor E Velculescu
Dec 14, 2004·Methods : a Companion to Methods in Enzymology·C BlanchetotM L Tremblay
Nov 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Xiangli Li, Sergei S Makarov
May 26, 2007·Nature Reviews. Immunology·Iain B McInnes, Georg Schett
Jan 8, 2008·Arthritis Research & Therapy·Ulf Müller-LadnerThomas Pap
Aug 5, 2008·Cell Cycle·Leila Wyatt, Yeesim Khew-Goodall
Sep 19, 2008·Nature Immunology·Tracy S P HengUNKNOWN Immunological Genome Project Consortium
Feb 22, 2011·Immunology Letters·Christopher D Buckley
Feb 7, 2012·Current Biology : CB·Ingrid PoernbacherHugo Stocker
Feb 15, 2012·The Journal of Experimental Medicine·Makiko FujiiYoshitaka Sekido
Sep 6, 2012·Genes & Development·Wenqi WangJunjie Chen
Nov 14, 2012·Nature Reviews. Rheumatology·Nunzio Bottini, Gary S Firestein
Jan 29, 2013·Science Signaling·Jane I LinKieran F Harvey
Feb 23, 2013·Genes & Development·Fa-Xing Yu, Kun-Liang Guan
Jul 16, 2014·The Journal of Biological Chemistry·Kayla E WilsonJianmin Zhang
Nov 8, 2014·Annals of the Rheumatic Diseases·Stephanie M StanfordNunzio Bottini
Feb 19, 2015·Science Signaling·Leila BelleYeesim Khew-Goodall
May 23, 2015·Science Translational Medicine·Karen M DoodyNunzio Bottini
May 17, 2018·Nature Communications·Rizi AiGary S Firestein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.